Sign in to view content

Efficacy, Safety, and Durability of Faricimab in Diabetic Macular Edema (DME): One-Year Results From the Phase 3 YOSEMITE and RHINE Trials

Caroline Baumal, MD, FASRS

Video
Published 2021

Related

Benefits and Value of Treatment for Diabetic Macular Edema
Paul Hahn, MD, PhD, FASRS
Updates from the Field
2022
Protocol U: Short-Term Evaluation of Combination Dexamethasone + Ranibizumab vs. Ranibizumab Alone for Persistent Central-Involv
Raj K. Maturi, MD
Updates from the Field
2017
Part 1: Screening Diabetic Patients and Capturing Those with Retinopathy through Collaboration with PCPs using PCP-stationed Fundus Cameras and Telemedicine
Jose Agustin Martinez, MD
On Demand Cases, Courses, and Papers
2017

Category: Diabetic Retinopathy

See more